Subscribe
farmer-3
fotografixx / iStockphoto.com
26 July 2018Biotechnology

CJEU tightens gene-editing rules with GMO decision

Genome-editing techniques, including CRISPR/Cas9, will be subject to more stringent regulations after a ruling from Europe’s highest court yesterday.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
CJEU gene-editing decision ‘could stifle’ innovation in Europe
30 July 2018   A ruling handed down last week by the Court of Justice of the European Union could stifle innovation in the gene-editing field, causing Europe to lag behind the rest of the world, commentators say.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Biotechnology
CJEU gene-editing decision ‘could stifle’ innovation in Europe
30 July 2018   A ruling handed down last week by the Court of Justice of the European Union could stifle innovation in the gene-editing field, causing Europe to lag behind the rest of the world, commentators say.

More on this story

Biotechnology
CJEU gene-editing decision ‘could stifle’ innovation in Europe
30 July 2018   A ruling handed down last week by the Court of Justice of the European Union could stifle innovation in the gene-editing field, causing Europe to lag behind the rest of the world, commentators say.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB